The mechanism by which steroid/thyroid nuclear hormone receptors activate gene transcription has been extensively studied (1-8). Among them there have been so many lines of solid evidence showing that vitamin D receptor (VDR), 1 thyroid hormone receptor, and retinoic acid receptor employ a common machinery to exert their ligand-dependent specific effects; all of them utilize a retinoic acid X receptor (RXR) in common as a partner of a heterodimer (2, 4). However, this mechanism seems to be confined only to gene stimulation but not to gene repression. This situation led us to address one of the key points in hormonal biology, negative feedback mechanism. The levels of almost all the hormones synthesized at a specific organ are under rigid control to keep their levels within a very narrow range. One of the representative mechanisms is the so-called end product inhibition. In the cases of the nuclear hormone receptors, negative transcriptional regulation of several pituitary trophic peptide hormone genes by glucocorticoid or sex steroid hormones is a good example. Although individual nuclear hormone receptors might well be involved in such regulation, detailed unified molecular mechanisms such as the manner of dimerization are largely unknown, with a few exceptions (9 -14). Likewise, the mechanism of negative gene regulation by VDR and vitamin D is only partially understood (15-21). In this case, an active form of vitamin D, 1,25-dihydroxyvitamin D 3 , can be considered an end product of parathyroid hormone (PTH) action, and this metabolite, in turn, inhibits the synthesis of PTH mRNA to keep the blood calcium level constant. Demay et al. (16) first reported that a negative vitamin D response element (nVDRE) exists in the upstream region of the human PTH gene to mediate such gene repression. This element contains a homologous sequence to only one of the two hexameric DNA sequences that form the core sequence of the consensus DNA sequence (VDRE) for positive gene regulation by vitamin D (2,4,(22)(23)(24)(25). In this process, it was shown that VDR, but not RXR, was involved, and the presence of another unknown partner protein(s) of VDR was proposed (17). However, there have been no reports confirming that the nVDRE is conserved among the genes whose expression is negatively regulated by vitamin D. We have found that the human PTH-related peptide (PTHrP) gene, which is assumed to be derived from an ancestoral gene in common with the PTH gene (26), contains a DNA sequence very homologous to the nVDRE of hPTH. Inoue et al. (27) reported that expression of the hPTHrP gene was inhibited by 1,25-dihydroxyvitamin D 3 at the transcriptional level in human adult T cell lymphoma/ leukemia virus-infected T cells, MT2 cells. With these cells, the therapeutic potential of vitamin D to decrease the blood calcium level due to the inhibition of PTHrP synthesis was discussed. Unlike parathyroid cells, from which it is hard to establish cultured cell lines, MT2 cells are transfectable cultured cell lines. Here, we examined the mole...